Caris Molecular Intelligence Registry

A Registry of Caris Life Sciences® Molecular Intelligence™ Service (Biomarker Assessment Results) Intended for Correlation With Cancer Clinical Outcomes

Status

Terminated

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02678754

Acronym

CMIR

Enrollment

4981

Registered

2016-02-10

Start date

2010-02-28

Completion date

2019-11-01

Last updated

2020-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Solid Tumors

Brief summary

This data collection Registry is a multi-center, observational outcomes Database designed to collect data on the demographics, presentation, diagnosis, treatment, resource use, quality of life and outcomes of subjects utilizing Caris Molecular Intelligence™ Services for treatment of solid tumor cancer.

Interventions

OTHERNo intervention required, purely observational

Study design

Observational model

OTHER

Time perspective

OTHER

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Age greater than or equal to 18 years, and * Solid Tumor analyzed by Caris Molecular Intelligence™ Service Profile(s) and/or Caris Next-Generation Sequencing

Exclusion criteria

* Individual test orders; defined as single biomarker assessment * Due to the complexity of state and federal requirements governing the participation of prisoners in research, prisoner-patients shall not be approached for participation in the Registry.

Design outcomes

Primary

Measure	Time frame
Documentation of the frequency of specific clinical events in relation to risk factors, diagnosis and treatments provided.	5 years per patient

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 13, 2026